Interview-Based Ratings of DSM-IV Axis IIDSM-5 Section II Personality Disorder Symptoms in Consecutively Admitted Insomnia Patients
Interview-Based Ratings of DSM-IV Axis IIDSM-5 Section II Personality Disorder Symptoms in Consecutively Admitted Insomnia Patients
PII: S0010-440X(18)30159-7
DOI: doi:10.1016/j.comppsych.2018.09.005
Reference: YCOMP 52033
To appear in: Comprehensive Psychiatry
Please cite this article as: Antonella Somma, Sara Marelli, Laura E. Giarolli, Cesare
Maffei, Luigi Ferini-Strambi, Andrea Fossati , Interview-based ratings of DSM-IV Axis
II/DSM-5 section II personality disorder symptoms in consecutively admitted insomnia
patients: A comparison study with consecutively admitted psychotherapy patients matched
on age and gender. Ycomp (2018), doi:10.1016/j.comppsych.2018.09.005
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 1
PT
RI
a: Faculty of Psychology, Vita-Salute San Raffaele University, Milan, Italy
SC
b: Sleep Disorder Unit, San Raffaele Hospital, Milan, Italy
c: Clinical Psychology and Psychotherapy Unit, San Raffaele Hospital, Milan, Italy
NU
MA
ED
PT
CE
AC
Correspondence concerning this article should be sent to Andrea Fossati, Clinical Psychology and
Psychotherapy Unit, San Raffaele Turro Hospital, via Stamira d’Ancona 20, 20127, Milan, Italy.
Abstract
perpetuating factors for insomnia, and previous studies stressed the importance to assess personality
Methods. In order to evaluate the relationships between DSM-IV axis II/DSM-5 Section II
Personality Disorders (PDs) and insomnia, a sample of 171 consecutively admitted insomnia
PT
patients and a sample of 171 psychotherapy patients, matched on age and gender were administered
RI
the Italian translation of the Structured Clinical Interview for DSM-IV Axis II Personality
SC
Disorders, Version 2.0 (SCID-II). Among insomnia patients, 52.0% (n = 89) received at least one
higher than the median and mean base rate estimates for any PD in the general population. Within-
MA
group analyses showed that Narcissistic, Not otherwise specified PD, Histrionic PD, and Borderline
II/DSM-5 Section II PD features in our insomnia patient sample. When continuously-scored PDs
were considered, insomnia patients showed a significantly lower number of Paranoid and
PT
Borderline PD features than psychotherapy patients; however, the corresponding effect size
CE
estimates suggested that these differences were modest. None of the categorically-scored PDs
Conclusions. As a whole, our findings seemed to suggest that personality dysfunction may play a
role in insomnia, while stressing the need for a dimensional approach to the assessment of
models.
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 3
1 Introduction
Insomnia is one of the most common sleep disorders, affecting 9–10% of the general
population in the United States [1], which may have a negative impact on psychological wellbeing
and quality of life [2] and may even predispose to other disorders, e.g., anxiety, depression,
substance use disorders [3]. Insomnia is defined as an ongoing difficulty in getting to sleep, staying
asleep, waking up too early or bad quality of sleep, accompanied by significantly impaired daytime
PT
functioning [4]. A model describing how (relatively stable) predispositions, precipitants and
RI
perpetuating factors interact to induce and maintain insomnia may help explaining the
SC
pathophysiology of many insomnia features [1; 5-6]. For instance, van de Laar and colleagues [1]
acutely pointed out that selected personality features may represent important predisposing and/or
NU
perpetuating factors for insomnia. Notably, high levels of neuroticism – i.e., the tendency to
experience a wide range of negative emotions [7] – were shown to increase the mood depressing
MA
literature that tried to assess the relationships between both general and pathological personality
traits, and insomnia. In their extensive review of the literature on this topic, van de Laar and
PT
colleagues [1] reported that in general insomnia patients showed elevations on measures of
CE
neuroticism and perfectionism personality traits. Recently, Dørheim and colleagues [9] documented
in a sample of 3752 pregnant women that neuroticism and agreeableness were associated with
AC
they pointed out that the exact causal relations remain controversial. Indeed, certain personality
features could play a predisposing role towards insomnia; however, the same features could be a
consequence of the negative impact of insomnia on daytime functioning [1]. Moreover, there are
several different theories to explain personality but – unfortunately – there is no unifying concept
[1]. To complicate this issue further, the exclusion of psychiatric disorders in an insomnia group
‘normalizes’ personality measurements [1]. These considerations led van de Laar and colleagues [1]
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 4
to stress the importance to assess personality disorders – as well as other psychiatric disorder – in
Based on extant meta-analyses of the published literature on sleep disorders and mental
disorders [10-11], a total of 10 studies were carried out on sleep disorders in personality disorders
(PDs); however, they focused almost exclusively (n = 9; 90.0%) on Borderline PD. Moreover, they
were small-sample studies; for instance, the five studies on sleep disorders in Borderline PD that
PT
were included in Baglioni and colleagues’ [11] meta-analyses provided data only on a total of 89
RI
subjects with Borderline PD and 85 control subjects. Interestingly, Baglioni and colleagues [11]
SC
reported that Borderline PD was characterized by reduced sleep continuity and depth (i.e., shorter
duration of sleep Stage 1, and longer duration of sleep Stage 2 and slow wave sleep) and heightened
NU
rapid-eye movement (REM) sleep pressure (defined by shorter REM latency, increased REM
density, and longer duration of REM sleep), although these findings were definitively non-specific.
MA
Studies specifically examining PDs and chronic insomnia suggested that Avoidant,
Dependent, and Obsessive–Compulsive PDs (i.e., DSM-IV axis II/DSM-5 Section II Cluster C PDs;
ED
[12-13]) and sub-threshold features of these disorders may co-occur with chronic insomnia and poor
sleep quality more than other PD clusters [14-16], even in adult subjects with chronic insomnia and
PT
hypnotic medication dependence [17]. Some studies suggested poor sleep quality even among
CE
Cluster A PD subjects [18]. Notwithstanding these relevant findings suggesting that insomnia
patients may show elevations on PD symptoms that are characterized by perfectionism (i.e.,
AC
Obsessive-Compulsive PD) and/or neuroticism (e.g., Avoidant PD), the majority of these studies
Although previous studies showed the importance of the relationship between insomnia and
PDs, research on the prevalence of PDs (including Cluster B PDs) in patients with insomnia, is still
limited [17]. Assessing PDs in patients suffering from insomnia may be helpful in tailoring standard
treatments to the needs of patients suffering from both insomnia and PDs; moreover, the value of
identifying PD features could be the development of preventive sleep education [e.g., 17].
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 5
Starting from these considerations, we aimed at testing the following research questions in a
sample of consecutively admitted insomnia patients: (1) Do insomnia patients show PD base rate
estimates that are significantly larger than the median/mean PD base rate estimates that were
reported for the general population in epidemiology studies?; (2) Are there selected DSM-IV axis
II/DSM-5 Section II PD that are significantly more frequent than other PDs in insomnia patients?;
PT
(3) Do insomnia patients show significant differences on PD frequency estimates when compared to
RI
a sample of psychotherapy patients of the same size who were matched on age and gender?
SC
Based on previous findings, we expected: (1) Insomnia patient sample PD base rate
estimates to be significantly higher than those reported for the general population [1; 9-11]; (2)
NU
Features of Cluster C and A personality disorders to be associated with insomnia [14-18]; (3)
Insomnia patients to show significantly lower rates of overall pathological personality traits than
MA
psychotherapy patients. The present research contributes to the field representing the first attempt at
systematically evaluating (e.g., using a semi-structured interview and a comparison group) the base
ED
rates of PDs in insomnia patients, representing the first step in assessing the need for developing
therapeutic techniques and coping strategies for individuals suffering from both insomnia and PDs.
PT
2 Methods
CE
2.1 Participants
The current study was based on insomnia participants (n = 171) and age- and sex-matched
AC
the Sleep Disorders Center of the San Raffaele Turro Hospital, after an initial assessment conducted
by a neurologist expert in sleep medicine. All participants with insomnia disorder met the clinical
criteria for chronic insomnia disorder according to International Classification of Sleep Disorders
(ICSD-3; [4]). To improve the accuracy of insomnia diagnosis, all participants completed the Italian
translations of the Pittsburg Sleep Quality Index [PSQI; 19] and the Insomnia Severity Index [ISI;
20]; mean values were 11.91 (SD = 3.07; Cronbach’s = .83) and 18.11 (SD = 4.05; Cronbach’s
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 6
= .79) for PSQI and ISI, respectively. All participants underwent two consecutive nights of
polysomnographic (PSG) recording to ensure correct diagnostic classification. All patients spent an
adaptation night before the PSG recording. Lights-out time was based on the individual’s usual
bedtime and ranged between 11:00 and 11:30 pm. The following signals were recorded:
mastoid); electrooculogram; electromyography (EMG) of the submentalis muscle; EMG of the right
PT
and left tibialis anterior muscles; electrocardiogram (one derivation) according to the American
RI
Academy of Sleep Medicine [21] scoring criteria. The sleep respiratory pattern of each patient was
SC
monitored using oral and nasal airflow thermistors and/or nasal pressure cannula, thoracic and
abdominal respiratory effort strain gauge, and by monitoring oxygen saturation (pulse-oximetry).
NU
Sleep stages were scored following standard criteria [e.g., 22] on 30-s epochs using the sleep
analysis software Hypnolab 1.2 (SWS Soft, Italy). Inclusion criteria were as follows: the absence of
MA
dementia, psychiatric disorders different from personality disorders, other sleep disorders and
neurological comorbidities. In addition, patients had to be drug-free for at least 2 months before
ED
Ninety-six (56.1%) participants were female and 75 (43.9%) were male; participants’ mean
PT
age was 40.88 years, SD = 10.48 years (range: 18-67 years). Subsequently, we relied on ‘e1071’ R
CE
package [23] to systematically match the insomnia patient sample with a large psychotherapy
patient sample (N = 507) based on the composition of age and gender in the insomnia participant
AC
sample. All psychotherapy participants were admitted to the Clinical Psychology and
Psychotherapy Unit in order to receive psychotherapy treatment for interpersonal difficulties and/or
problems with behavior and emotional regulation on a strictly voluntary basis. Potential participants
were screened for the following exclusionary criteria: (1) age less than 18 years; (2) IQ less than 80;
disorder according to DSM-IV diagnostic criteria; (4) diagnosis of dementia or organic mental
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 7
disorder according to DSM-IV diagnostic criteria; and (5) education level lower than elementary
school. All participants in the current research passed this screening procedure.
2.2 Procedure
All participants volunteered to take part in the study after being presented with a detailed
description of all aspects of the study and signed a written informed consent. All participants were
at least 18 years old when the study was carried out. Participants were administered all measures as
PT
part of their routine clinical assessment; IRB approval was obtained for all aspects of this study.
RI
Participants were treated in accordance with the Ethical Principles of Psychologists and Code of
SC
Conduct, and none of them received an incentive, either directly or indirectly for participating. The
SCID-II was administered by expert (Doctor of Psychology) clinicians who received extensive
NU
training in SCID-II assessment; clinicians were kept blind to the aims of the study and to the
2.3 Measures
2.3.1 Structured Clinical Interview for DSM-IV Axis II Personality Disorders, Version 2.0 [24]. The
ED
dimensional (i.e., number of criteria) assessment of DSM-IV Personality Disorders (PDs). The
PT
SCID-II was preceded by administration of its self-report screening questionnaire (PQ). The
CE
interrater reliability and internal consistency of the Italian translation of the SCID-II in clinical
participants were assessed in a previous study [25]. Although the SCID II was developed to asses
AC
DSM-IV axis II PDs, we considered it as a measure of DSM-5 Section II PDs because the PD
diagnostic criteria in the DSM-5 Section II were retained with no changes from the DSM-IV axis II
(APA, 2013). Thus, in the present study, we considered only the 10 PD diagnoses that were retained
impressive amount of taxometric data documented that PDs are dimensional in nature [26-27], and
that the use of arbitrary diagnostic thresholds may result in severe loss of clinical (and research)
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 8
information [28]. Thus, in the present study we relied both on continuously-scored (i.e., number of
Clinicians who administered the interviews were kept blind to the aim of the study, as well
as to the subject’s condition (insomnia vs. psychotherapy group). Because six Doctor of Psychology
(PsyD) expert clinicians trained in administering the SCID-II participated in the present study, we
used a pairwise interview design in order assess the inter-rater reliability of the SCID-II diagnoses.
PT
In the present study, the interrater reliability of SCID-II diagnoses was assessed on the first 60
RI
(17.5%) consecutively admitted participants. For each of the first 60 participants, two interviewers
SC
were randomly extracted and assigned the role of interviewer and independent rater, respectively;
each clinical psychologist acted the same number of times as interviewer or independent rater. In
NU
the present study, the ICC values for the individual SCID-II PD dimensional counts ranged from .83
(Antisocial PD) to .99 (Obsessive-Compulsive PD), median ICC value = .92, SD = .05, all ps <.001.
MA
The chance-corrected agreement (i.e., Cohen κ coefficient value) on any PD diagnosis was .92, p
<.001, whereas a Cohen κ value for the individual SCID-II PD diagnosis ranged from .83
ED
(Antisocial PD) to .99 (Obsessive-Compulsive PD), median ICC value = .92, SD = .05, all ps <.001.
Shapiro-Wilk and Kolmogorov-Smirnoff tests were used for checking normality of the
continuously-scored DSM-IV axis II/DSM-5 Section II PDs scores. If the assumption of normality is
AC
violated, non-parametric statistics will be employed. Mann-Whitney U tests were used to compare
continuously-scored DSM-IV Axis II/DSM-5 Section II PD means between insomnia patients and
psychotherapy patients; Rosenthal’s [29] r was used as an effect size measure for Mann-Whitney
test. The nominal significance level (i.e., p <.05) for Mann-Whitney U tests was corrected
according to the Bonferroni procedure (i.e., p <.0045). Following Newcombe’s [30] indications, we
relied on relative risk (RR) to evaluate both significance (i.e., p <.0042) and effect size of the
differences in PD proportions that were observed between insomnia patients and psychotherapy
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 9
patients. Within each sample, repeated measure Dunn-Bonferroni post-hoc contrasts were used to
scored DSM-IV Axis II/DSM-5 Section II PDs frequencies. Friedman repeated-measure ANOVA
followed by Dunn-Bonferroni post-hoc comparisons were run to assess mean rank differences in
continuously-scored PDs within both insomnia patients and psychotherapy patients; since a total of
20 ANOVAs were performed, the Bonferroni nominal significance level (i.e. p <.05) was corrected
PT
according to the Bonferroni procedure and set at p <.0025. Cochran Q values were used to evaluate
RI
the existence of significant differences among PD base rate estimates in both samples. Binomial test
SC
with two-tailed p-value was used to carry out statistical comparisons between PD base rate
estimates in our samples and corresponding median/mean prevalence estimates for the general
NU
population. The relationships between the polysomnographic data, PSQI scores, ISI scores, and
continuously scored PDs was assessed using Spearman r correlation coefficient ().
MA
3 Results
Demographic characteristics of the insomnia participant sample and age- and sex-matched
ED
psychotherapy patient participants are listed in Table 1. Continuously-scored DSM-IV axis II/DSM-
5 Section II PDs were not normally distributed in both insomnia patient sample, Shapiro-Wilks
PT
statistic median value = .60, min. = .07 (Antisocial PD), max. (overall number of PD criteria) = .96,
CE
all ps <.001, and psychotherapy patient sample, Shapiro-Wilks statistic median value = .68, min. =
.21 (Schizotypal PD), max. (overall number of PD criteria) = .95, all ps <.001. Similar findings
AC
were observed when we relied on Kolmogorov-Smirnoff test for assessing PD score normal
When we considered the relationships between the polysomnographic data, PSQI scores, ISI
scores, and continuously scored PDs, as a whole, no significant association was observed. In our
insomnia patient sample, PSG data and continuously scored PDs were not significantly associated,
median = .02, SD = .07. Similarly, no significant association was observed between DSM-IV Axis
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 10
II/DSM-5 Section II PD continuous ratings and PSQI scores (median = .04, SD = .11), and ISI
3.1 Median/Mean Personality Disorder Base Rate Comparisons: Insomnia Patient vs. General
Comparisons between PD base rate estimates in our insomnia patient sample and
corresponding median/mean prevalence estimates for the general population [31] are summarized in
PT
Table 2. Interestingly, the base rate estimate for any PD diagnosis in our insomnia patients was
RI
significantly lower than both Torgersen’s [31] median value (65.6%; z = -3.74, two-tailed p <.001)
SC
and mean value (64.4%; z = -3.39, two-tailed p <.001) for psychiatric samples.
Of course, the base rate estimate (72.5%) for any PD diagnosis in our psychotherapy patient
NU
sample was significantly higher than median (z = 24.47, two-tailed p <.001) and mean (z = 25.70,
two-tailed p <.001) base rate estimates for the general population [31]. When we compared the any
MA
PD base rate estimate in our psychotherapy patient sample with the median value for psychiatric
samples [31], we observed no significant difference, z = 1.90, two-tailed p >.05; however, our base
ED
rate estimate was significantly higher than the mean base rate estimate for any PD diagnosis in
PT
3.2 Frequency of DSM-IV axis II/DSM-5 Section II PDs in the Insomnia Patient Sample:
CE
Considering the individual DSM-IV axis II/DSM-5 Section II PDs and the number of DSM-
IV axis II/DSM-5 Section II PD criteria in the insomnia patient sample and in the psychotherapy
comparisons are summarized in Table 3. For ease of presentation, the DSM-IV axis II/DSM-5
Section II PDs are listed in DSM-5 Section II order. In both samples, the sum of the frequency of
subjects who received specific PD diagnoses exceeded the frequency of subjects who received at
least one PD diagnosis because of multiple PD diagnoses. Means and frequencies with different
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 11
superscripts were significantly different (i.e., p <.05) in repeated measure Dunn-Bonferroni post-
hoc contrasts. For instance, Narcissistic PD showed a significantly higher mean number of PD traits
than all other PDs, whereas the mean number of Paranoid PD and Schizoid PD was not significantly
different.
Friedman repeated-measure ANOVA results showed that the ten continuously-scored PDs
had significant mean rank differences within both insomnia patients, H(9) = 415.41, p <.001,
PT
2Friedman = .27, and psychotherapy patients, H(9) = 309.80, p <.001, 2Friedman = .20. As it can be
RI
seen in Table 3, Dunn-Bonferroni post-hoc comparisons indicated that continuously-scored
SC
Narcissistic PD showed a significantly higher mean rank value than all other continuously scored
PDs in both samples. Similar considerations held for categorically-rated DSM-IV axis II/DSM-5
NU
Section II PD diagnoses. Cochran Q values suggested the existence of significant differences
among PD base rate estimates both in the insomnia patient sample, Q = 149.47, p <.001, I2 = 93.3,
MA
4 Discussion
ED
Confirming and extending previous evidence [1; 10-11], our findings seemed to suggest that
personality dysfunction, at least as it was operationalized in the DSM-5 Section II, may play a role
PT
factor, or simply a consequence of the impact of insomnia on daily life [1; 5]. It should be observed
that our data were based on expert clinician’s ratings of PDs who administered the SCID-II blind to
AC
study aims and subject status (i.e., insomnia patient vs. psychotherapy patient). Moreover, we relied
on a psychotherapy patient control group of the same size, whose members were carefully matched
on age and gender. Finally, to our knowledge our study represented the first attempt at considering
PD prevalence rates in insomnia patients also in comparison with epidemiological data [31].
4.1 Do insomnia patients show PD base rate estimates that are significantly larger than the
median/mean PD base rate estimates that were reported for the general population in
epidemiology studies?
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 12
According to our findings more than 50% of the insomnia patients received at least one
DSM-IV axis II/DSM-5 Section II PD diagnosis; moreover, our insomnia patients met on average
roughly six PD criteria. It should be observed that in our study dysfunctional personality traits were
extensively assessed by expert clinicians using a semi-structured interview (i.e., the SCID-II) who
were blind to patient’s group membership, rather than relying on patients’ self-reports.
In our study, the any PD base rate estimate in our insomnia patient sample was significantly
PT
and markedly higher than the median (proportion difference = 40.0%) and mean (proportion
RI
difference = 41.0%) base rate estimates for any PD in the general population [31]. When compared
SC
to epidemiological mean/median prevalence data for psychiatric samples [31], our insomnia
patients showed significantly lower rates of overall dysfunctional personality traits, although the
NU
differences in proportions were in the 12%-14% range, suggesting small differences. Interestingly
our psychotherapy control group was at least as characterized by dysfunctions in personality as, not
MA
to say more, than the average (i.e., mean/median) psychiatric sample in international clinical
populations [33].
ED
Thus, in terms of general amount of personality dysfunction, our data suggest that insomnia
patients are sharply different from the general population, while manifesting a significantly, albeit
PT
patients. Consistent with previous studies [1; 10-11], our findings indicate the importance of
4.2 Are there selected DSM-IV axis II/DSM-5 Section II PD that are significantly more
specification PD, Histrionic PD, and Borderline PD represented the most frequently diagnosed -
both dimensionally and categorically - DSM-IV axis II/DSM-5 Section II PD features in our
insomnia patient sample; rather, Paranoid, Schizoid, Schizotypal, and Antisocial PD features were
diagnosed significantly less than most of the other DSM-IV axis II/DSM-5 Section II PDs. These
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 13
findings seemed to be at least partially consistent with previous reports [14-16; 18] based on self-
report measures which documented that specific PDs have different base rate estimates in insomnia
patients. We are aware that our data are somewhat at variance with the findings of self-report
studies, which documented and excess of Cluster C PDs in insomnia patients [14-17]. Although
sampling differences may partially explain these differences, it is known that relying on self-reports
and interview-based measures to assess DSM-IV axis II/DSM-5 Section II PDs is likely to result in
PT
very different estimates, mostly because of poor convergent validity of the PD instruments [34].
RI
Although no “gold standard” has been identified for PD assessment, semi-structured interviews
SC
represent a major resource for PD evaluation [34].
Interestingly, both Borderline and Narcissistic PDs have been consistently linked to emotion
NU
dysregulation [35-36], which represents a dysfunctional personality features that has been
empirically linked to insomnia [37]. Moreover, previous studies [e.g., 38], showed the existence of
MA
a relationship between specific PDs characterized by high levels of antagonism (i.e., behaviors that
put the individual at odds with other people; 13) and insomnia, also among forensic psychiatric
ED
inpatients [e.g., 38-39]. Finally, Sabouri and colleagues [40] examined the associations between
dark triad traits (i.e., narcissism, Machiavellianism, and psychopathy), and sleep disturbances in a
PT
sample of young adults, and found that Machiavellianism and psychopathy were associated with
CE
sleep disturbances. As a whole, these findings seemed to stress the importance of studying the
relationship between antagonistic personality traits and insomnia, while suggesting the potential
AC
compared to a sample of psychotherapy patients of the same size who were matched on age
and gender?
In our study, the overall amount of personality pathology, both continuously-scored (i.e., n.
of PD symptoms) and categorically-scored (i.e., any PD diagnosis base rate), was significantly
larger in the psychotherapy patient control group than in the insomnia patient sample; however, the
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 14
size of these differences may be considered small by conventional standards [32-33]. Interestingly,
the insomnia patient pattern of within-group differences among both continuously-scored and
categorically-assessed PDs was reproduced with minimal differences also in our psychotherapy
patient sample. Although this result may have been influenced by sampling participants in both
groups from the same hospital, it seems to indicate that insomnia patients are pretty similar to
psychotherapy patients in terms of the shape of the maladaptive personality traits profile.
PT
As a whole, between-group contrasts on individual PDs seemed to support the hypothesis
RI
that insomnia patients were simultaneously similar to psychotherapy patients and different from
SC
general population data [31] only on selected PDs. When continuously-scored PDs were
considered, insomnia patients showed a significantly lower number of Paranoid and Borderline PD
NU
features than psychotherapy patients; however, the corresponding effect size estimates suggested
that these differences were modest [32]. Interestingly, none of the categorically-scored PDs
MA
significantly differentiated insomnia patients from psychotherapy patients. Although this finding
may reflect the loss of statistical power that occurs when continuous variables are discretized [41],
ED
it seems also to indicate the frequency of extreme scorers (i.e., subjects scoring above the PD
diagnostic threshold) may not be different in insomnia patients and psychotherapy patients for all
PT
DSM-IV axis II/DSM-5 Section II PDs, at least when they were assessed using the SCID-II.
CE
4.4 Conclusions
Histrionic, and Narcissistic PDs significantly discriminated insomnia patients from general
population base rate estimates [31]; at the same time, these PDs showed approximately the same
base rates in insomnia patients and psychotherapy patients. In our opinion, this finding seemed to
confirm and extend previous evidence on the association between Borderline PD and sleep
disorders [10-11], suggesting that Borderline, Histrionic and Narcissistic PDs may represent core
personality problems in insomnia patients, making them akin to a sample of psychiatry patients
voluntarily seeking for psychotherapy treatment because of personality problems (i.e., our
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 15
psychotherapy patient sample). Of course, we do not mean to say that personality disorders always
occurs in insomnia patients or that it has a causal role in insomnia disorders. Rather, we suggest that
maladaptive personality traits should be routinely assessed and taken into account in insomnia
patient treatment, independent from whether it has a predisposing or perpetuating role in insomnia
[1]. Indeed, it would be consistent with integrated theories and models about the etiology and
pathophysiology of insomnia [e.g., 6]. For instance, the hyperarousal model of insomnia
PT
emphasizes an interplay between psychological (e.g., personality traits) and physiological factors in
RI
the etiology and perpetuation of chronic insomnia [e.g., 6]. Moreover, these aspects may be
SC
particularly relevant considering that previous studies found an association between personality
characteristics and insomnia treatment outcomes [e.g., 1]. Future studies may examine the effect of
NU
tailored treatment strategies insomnia patients, for instance taking into account the role of PD
Finally, our data seemed to be in line with studies suggesting the need for adopting
insomnia patients and psychotherapy patients (although qualitative differences between the two
PT
groups were observed in these correlation patterns), suggesting that DSM-IV axis II/DSM-5 Section
CE
II PDs represent poorly separated constructs [28]. Moreover, in terms of overall personality
than to general population sample, while being significantly different even from the former. This
finding is highly consistent with a dimensional distribution of maladaptive personality traits, which
could be hardly described in terms of DSM-5 Section II PDs [28]. Notably, an Alternative Model of
Personality Disorder was provided in DSM-5 Section III [13], along with traditional PD symptom
criteria listed in DSM-5 Section II. A core component of the DSM-5 AMPD is an empirically based
model of maladaptive personality domain and traits which represents dysfunctional variants of the
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 16
Five Factor Model personality dimensions [13]. This system of dysfunctional traits may be used in
4.5 Limitations
Of course, we feel that the results of our study should be considered in the light of several
limitations. Our study was based in a cross-sectional design; indeed, longitudinal studies are needed
to clarify if personality features actually represent risk factors for insomnia, or if they rather
PT
represent long-term behavior modifications due to the impact of insomnia on daily life. Although
RI
we relied on consecutive admissions to select our participants, our data should be considered based
SC
on convenience study groups rather than on actually representative samples.
In the present study, we did not find any significant association between PSG data and
NU
continuously scored PDs. In their meta-analysis, Baglioni and colleagues [11] observed that sleep
continuity, sleep depth, and REM sleep disturbances may be associated with Borderline PD. In a
MA
sense, our findings extend previous studies [for quantitative reviews, see 10-11] on the relationships
sound inter-rater reliability data, we were not able to assess the insomnia base rate among
PT
personality-disordered psychotherapy control patients. Moreover, we were not able to assess sleep
CE
quality and quantity among participants undergoing psychotherapy; these aspects represent major
limitations of our study, and they stress the need of further studies on this topic. When compared to
AC
Torgersen’s [31] data, our psychotherapy control patients showed a number of differences in base
rate estimates for individual PDs in international clinical populations. Although other explanations
may be possible, e.g., heterogeneity in PD base rate estimates [31], we feel that the main reason for
discrepant findings was the fact that our control groups was not composed by general psychiatry
patients; rather, it included only patients who voluntarily asked for psychotherapy treatment
References
2. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with
3. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an
PT
opportunity for prevention? J Am Med Assoc 1989;262:1479–84.
RI
4. American Academy of Sleep Medicine. International Classification of Sleep Disorders:
SC
Diagnostic and Coding Manual, 3rd edn. American Academy of Sleep Medicine:
hyperarousal model of insomnia: A review of the concept and its evidence. Sleep Med Rev
ED
2010;14:19-31.
7. John, O. P., & Srivastava, S. (1999). The Big Five Trait taxonomy: History, measurement, and
PT
theoretical perspectives. In L. A. Pervin & O. P. John (Eds.), Handbook of personality: Theory and
CE
8. Blagrove M, Akehurst L. Personality and the modulation of effects of sleep loss on mood and
AC
10. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders. A meta-
11. Baglioni C, Nanovska S, Regen W, Spiegelhalder K, Feige B, Nissen C et al. Sleep and mental
12. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders
13. American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders
14. Tan TL, Kales JD, Kales A, Soldatos CR, Bixler EO. Biopsychobehavioral correlates of
PT
15. Mahendran R, Subramaniam M, Chan YH. Psychiatric morbidity in patients referred to an
RI
insomnia clinic. Singapore Med J 2007;48:163–5.
SC
16. Schramm E, Hohagen F, Kappler C, Grasshoff U, Berger M. Mental comorbidity of chronic
insomnia in general practice attenders using DSM-III-R. Acta Psych Scand 1995;91:10–7.
NU
17. Ruiter M, Lichstein K, Nau S, Geyer J. Personality disorder features and insomnia status
18. Atalay H. Comorbidity of insomnia detected by Pittsburgh Sleep Quality Index with anxiety,
19. Curcio G, Tempesta D, Scarlata S, Marzano C, Moroni F, Rossini PM, ... et al. Validity of the
Italian version of the Pittsburgh sleep quality index (PSQI). Neurol Sci 2013;34:511-9.
PT
20. Castronovo V, Galbiati A, Marelli S, Brombin C, Cugnata F, Giarolli L, et al. Validation study
CE
of the Italian version of the Insomnia Severity Index (ISI). Neurol Sci 2016;37:1517-24.
21. AASM (American Academy of Sleep Medicine). International classification of sleep disorders.
AC
22. Iber C, Ancoli-Israel S, Chesson A, Quan S. The AASM manual for the scoring of sleep and
associated events: rules, terminology and technical specifications. American Academy of Sleep
23. Meyer D, Dimitriadou E, Hornik K, Weingessel A, Leisch F (2017). e1071: Misc Functions
24. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin L. Structured clinical interview for
DSM-IV axis II personality disorders. New York, NY: Biometric Research Department; 1994
25. Maffei C, Fossati A, Agostoni I, Barraco A, Bagnato M, Deborah D et al. Interrater Reliability
and Internal Consistency of the Structured Clinical Interview for DSM-IV Axis II Personality
PT
psychopathology: a quantitative review of taxometric research. Psychol Med 2012;42:903-20.
RI
27. Coghill D, Sonuga-Barke E. Annual Research Review: Categories versus dimensions in the
SC
classification and conceptualisation of child and adolescent mental disorders - implications of
29. Rosenthal R, 1991. Meta-analytic procedures for social research (revised). Newbury Park,
CA: Sage.
ED
30. Newcombe R. A deficiency of the odds ratio as a measure of effect size. Stat Med.
2006;25:4235-40.
PT
Psychiatric Publishing Textbook of Personality Disorders, JM. Oldham, AE. Skodol, DS. Bender,
32. Cohen J. Statistical power analysis for the behavioral sciences. New York, NY: Psychology
33. Olivier J, May W, Bell M. Relative effect sizes for measures of risk. Commun Stat Theory
Methods 2017;46:6774-81.
Development, Factor Structure, and Initial Validation of the Difficulties in Emotion Regulation
36. Pincus A, Lukowitsky M. Pathological Narcissism and Narcissistic Personality Disorder. Annul
37. Brand S, Kirov R, Kalak N, Gerber M, Pühse U, Lemola S et al. Perfectionism related to self-
PT
reported insomnia severity, but not when controlled for stress and emotion regulation.
RI
Neuropsychiatr Dis Treat 2015; 263-71.
SC
38. Kamphuis J, Karsten J, de Weerd A, Lancel M. Sleep disturbances in a clinical forensic
40. Sabouri S, Gerber M, Lemola S, Becker SP, Shamsi M, Shakouri Z, et al. Examining Dark
Triad traits in relation to sleep disturbances, anxiety sensitivity and intolerance of uncertainty in
ED
41. Cohen J, Cohen P, West S, Aiken L. Applied multiple regression/correlation analysis for the
PT
Table 1.
Demographic Characteristics of the Insomnia Participant Sample (n = 171) and Age- and Sex-
Matched Psychotherapy Patient Participants (n = 171).
PT
RI
SC
NU
MA
ED
PT
CE
AC
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 22
Table 2.
DSM-IV Axis II/DSM-5 Section II Personality Disorders in Insomnia Patients (n = 171): Comparisons with
Epidemiological Mean and Median Prevalence Estimates [31] in General Population.
PT
Antisocial PD 0.6% 1.0% -0.53 1.8% -1.18
Borderline PD 6.4% 1.7% 4.75*** 1.6% 5.00***
Histrionic PD 8.2% 0.7% 11.76*** 1.2% 8.41***
***
Narcissistic PD 19.9% 0.7% 30.11 0.8% 28.04***
RI
Avoidant PD 1.2% 2.3% -0.96 2.7% -1.21
Dependent PD 0.6% 1.0% -0.53 1.0% -0.53
Obsessive-Compulsive PD 3.5% 2.0% 1.40 2.5% 0.84
SC
Any PD diagnosis 52.0% 11.9% 16.20*** 11.0% 17.14***
Note. PD: Personality Disorder; P: Base rate expressed as percentage; Mdn P: Median prevalence estimate in
Torgersen’s [31] study expressed as percentage; 𝑃̅ : Mean prevalence estimate in Torgersen’s [31] study expressed as
percentage; z: Binomial test z.
NU
*** p (two-tailed) <.0023
MA
ED
PT
CE
AC
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 23
Table 3.
DSM-IV Axis II/DSM-5 Section II Personality Disorders in Insomnia Patients (n = 171) and Psychotherapy Patients Matched on Age and Gender (n = 171):
Descriptive Statistics, Nonparametric Within-group and Between-group Comparisons.
P TPsychotherapy
R I Patients
SC
M SD M SD U z rES n % n % RR z
DSM-5 Section II PDs
a, b b *** a a
Paranoid PD 0.11 0.40 0.50 0.96 11650.00 -4.84 -.25 0 0.0 4 2.3 0.11 1.47
0.08 a 0.08 a 2 a, b 1a
U
Schizoid PD 0.57 0.31 14036.50 -1.80 -.09 1.2 0.6 2.00 0.57
Schizotypal PD 0.02 a 0.13 0.12 a 0.60 13846.50 -2.39 -.12 0 a, b 0.0 3a 1.8 0.14 1.29
Antisocial PD
Borderline PD
Histrionic PD
0.02 a
0.70 b, c
1.04 c
0.24
1.66
1.52
0.16 a
1.37 c
1.08 b, c
0.76
2.15
1.70
13765.00
11357.50
14204.00
-2.73
A
-4.23***
-0.51
N
-.14
-.22
-.03
1 a, b
11 c, d, e
14 d, e
0.6
6.4
8.2
4 a, b
20 c, d
14 b, c
2.3
11.7
8.2
0.25
0.55
1.00
1.25
1.66
0.00
Narcissistic PD
Avoidant PD
2.12 d
0.49 c
1.97
0.90
2.23 d
0.56 b, c
2.14
1.10
14466.50
14578.50 M -0.17
-0.06
-.01
.00
34 f
2 a, b, c
19.9
1.2
39 d
6 a, b, c
22.8
3.5
0.87
0.33
0.66
1.36
Dependent PD
Obsessive-Compulsive PD
0.47 c
0.68 c
0.88
1.19
0.79 b, c
0.72 b, c
1.18
1.11
E D
12514.50
13901.50
-2.70
-0.91
-.14
-.05
1 a, b
6 b, c, d
0.6
3.5
5 a, b
4 a, b
2.9
2.3
0.20
1.50
1.48
0.64
T
Not otherwise specified/with
24 e, f 14.0 38 d 22.0 0.60 2.17
other specification PD
N. of PD criteria
Any PD diagnosis
5.64 3.34
E P
7.46 4.82 11568.50 -3.35*** -.17
89 52.0 124 72.5% 0.72 3.80***
C C
Note. PD: Personality Disorder; rES: Rosenthal’s [29] effect size measure; U: Mann-Whitney U statistic; RR: Relative risk. Means and frequencies with different superscripts were
significantly different (i.e., p <.05) in repeated measure Dunn-Bonferroni post-hoc contrasts (e.g., Narcissistic PD showed a significantly higher mean number of PD traits than all
A
other PDs, whereas the mean number of Paranoid PD and Schizoid PD was not significantly different).
*** p <.0045
ACCEPTED MANUSCRIPT
DSM-IV AXIS II/DSM-5 SECTION II PDS IN INSOMNIA 24
Highlights
We evaluated 171 insomnia patients and a matched sample of 171 psychotherapy patients.
PT
RI
SC
NU
MA
ED
PT
CE
AC